Navigation Links
Allergy Technologies LLC Provides Over $100,000 in a Research Grant to The Ohio State University for the Study of Bed Bugs
Date:8/9/2011

AMBLER, Pa., Aug. 9, 2011 /PRNewswire/ -- Allergy Technologies LLC, manufacturer of ActiveGuard™ mattress liners, is sponsoring a new bed bug research program at The Ohio State University through an initial $100,000+ grant provided by the Company.

This new endeavor will examine the importance and effects of specific products, protocols and strategies relating to innovative bed bug treatment applications. The dramatic rise in bed bug infestations throughout the country in the last ten years has created a need for more research to improve and expand pest management practices. Based on mutual agreement between The Ohio State University and Allergy Technologies, this grant provides a 2nd year renewal opportunity for an additional $100,000+ in funding.

According to Susan Jones, Ph.D., entomologist at The Ohio State University, the grant provided by Allergy Technologies will allow Jones and her urban entomology team to pursue sorely needed bed bug-related research leading to implementation of new and improved strategies for controlling bed bugs.

"This grant will enable us to embark upon important and in-depth research on product efficacy, treatment protocols, and application methods as we work to control bed bugs," said Dr. Jones. "With the current emergence of bed bug infestations, Allergy Technologies' sponsorship will allow us to pursue fundamental lab and applied field research.  This programmatic research is geared toward investigating novel strategies in bed bug treatment leading to improved and effective solutions."

"We are proud to be able to support this university research.  This grant evidences Allergy Technologies' continued commitment to developing bona fide research-based treatments aimed directly toward the bed bug scourge that is blanketing our country," stated Gus Carey, Managing Director of Allergy Technologies.

ActiveGuard by Allergy Technologies LLC, is a thin and breathable liner easily installed onto mattresses and box springs, which kill bed bugs and dust mites continuously for up to two years.

According to Joseph Latino, Director of Technical Services for Allergy Technologies, "We are highly optimistic that the findings from these studies will benefit the entire pest management industry toward reaching a common goal - establishing rigorous scientifically supported treatment options for controlling bed bugs."

Distinct from encasements and originally developed as a natural extension of the globally used mosquito nets by a team of research entomologists for use against dust mites, ActiveGuard has been extensively lab and field tested for use in both active and preventative bed bug control strategies.

About Allergy Technologies

Allergy Technologies is a subsidiary of A. Carey Co. LLC, which focuses on using philanthropy as a core business strategy for its businesses. Through its Philanprofit strategy, a portion of all ActiveGuard proceeds go to help fund inner-city homeless and women's shelters and asthma clinics.

For more information, call (866) 978-6288 or visit www.allergytechnologies.com.

Media Contact:
Ed DeMask
DeMask Marketing
630-768-1404, cell
630-389-0572, office
ed@demaskmarketing.com


'/>"/>
SOURCE Allergy Technologies LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Food Allergies Common among Children and Linked to Environmental Allergies and Asthma Later in Life, Suggests Largest-Ever National Allergy Study
2. Cobalis Corp. Launches National Television Commercials for PreHistin® Allergy Defense Formula
3. Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week
4. Allergy Relief Moms Can Rely On
5. Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting
6. National Nasal Allergy Survey Reveals Unmet Needs Still Exist Among Patients Living With Allergic Rhinitis
7. PreHistin ® Allergy Defense Formula Wins 2011 Best New Product Award at ECRM Allergy Show
8. Sams Club® Offers Free Allergy Health Screenings
9. Cobalis Corp. Receives $415,000 First Purchase Order from Major Retail Pharmacy for PreHistin® Allergy Defense Formula
10. Good Clostridia in the Gut Protect from Allergy and Autoimmunity
11. Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... ORANGE COUNTY, Calif. , Oct. 10, 2017  NDS received ... Mobile  — a medical-grade battery-powered display stand specifically designed for ... aims to transform technology into a clinical solution to support the ... costs. Innovative Design ... NDS ZeroWire Mobile Wireless Solution ...
(Date:10/7/2017)... IRVING, Texas , Oct. 6, 2017   ... industry with more than $100 billion in purchasing power, ... industry news and information. The Newsroom is ... chain and industry trends, infographics, expert bios, news releases, ... Besides having access to a wealth of resources at ...
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards luncheon ... editorial and design excellence across a range of sectors. This year’s program included the ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):